跳轉至內容
Merck
全部照片(1)

Key Documents

21878

Sigma-Aldrich

5 (6)-羧基荧光素 N -羟基琥珀酰亚胺酯

BioReagent, suitable for fluorescence, mixture of isomers, ≥80% (HPLC)

同義詞:

5 (6)-溶剂, FLUOS

登入查看組織和合約定價


About This Item

經驗公式(希爾表示法):
C25H15NO9
CAS號碼:
分子量::
473.39
MDL號碼:
分類程式碼代碼:
12352108
PubChem物質ID:
NACRES:
NA.32

品質等級

產品線

BioReagent

化驗

≥80% (HPLC)

形狀

powder

溶解度

DMF: soluble
DMSO: soluble

螢光

λex 492 nm; λem 517 nm in DMF

適合性

suitable for fluorescence

儲存溫度

−20°C

SMILES 字串

OC(=O)c1ccc(cc1C2=C3C=CC(=O)C=C3Oc4cc(O)ccc24)C(=O)ON5C(=O)CCC5=O.OC(=O)c6cccc(C(=O)ON7C(=O)CCC7=O)c6C8=C9C=CC(=O)C=C9Oc%10cc(O)ccc8%10

InChI

1S/2C25H15NO9/c27-13-2-5-16-19(10-13)34-20-11-14(28)3-6-17(20)23(16)18-9-12(1-4-15(18)24(31)32)25(33)35-26-21(29)7-8-22(26)30;27-12-4-6-14-18(10-12)34-19-11-13(28)5-7-15(19)22(14)23-16(24(31)32)2-1-3-17(23)25(33)35-26-20(29)8-9-21(26)30/h1-6,9-11,27H,7-8H2,(H,31,32);1-7,10-11,27H,8-9H2,(H,31,32)

InChI 密鑰

YVTPVJDECOUTJW-UHFFFAOYSA-N

尋找類似的產品? 前往 產品比較指南

應用

5 (6)-羧基荧光素 N -羟基琥珀酰亚胺酯 (5 (6)-FAM SE, FLUOS) 可用于制备蛋白质如微管蛋白的荧光衍生物,并用于制备苯妥英示踪剂,以通过荧光偏振免疫分析 (FPIA) 和激光诱导荧光检测测定血清和血浆中该药物和其他药物。
已用于制备微管蛋白的荧光衍生物,并用于制备苯妥英示踪剂,以通过荧光偏振免疫分析法 (FPIA) 测定血清和血浆中该药物
蛋白质和其他生物分子上伯胺和仲胺基团的荧光标记。

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

Federica De Santis et al.
PloS one, 14(3), e0213150-e0213150 (2019-03-05)
In nature, many plants or their extracted compounds have been found to possess anti-inflammatory features and therapeutic properties against infectious as well as non-infectious diseases, including cancer. In this study, we analysed the immunomodulatory effects on innate immune cells of
Teruhisa Takagishi et al.
Scientific reports, 7(1), 5217-5217 (2017-07-14)
Clostridium perfringens α-toxin induces hemolysis of erythrocytes from various species, but it has not been elucidated whether the toxin affects erythropoiesis. In this study, we treated bone marrow cells (BMCs) from mice with purified α-toxin and found that TER119
Farhat Afrin et al.
PLoS neglected tropical diseases, 13(5), e0007227-e0007227 (2019-05-10)
There is a pressing need for drug discovery against visceral leishmaniasis, a life-threatening protozoal infection, as the available chemotherapy is antiquated and not bereft of side effects. Plants as alternate drug resources has rewarded mankind in the past and aimed
Seyedeh Masoumeh Ghoreishi et al.
International journal of nanomedicine, 13, 4671-4683 (2018-08-30)
Nowadays, molecular imaging radiopharmaceuticals', nanoparticles', and/or small-molecule biomarkers' applications are increasing rapidly worldwide. Thus, researchers focus on providing the novel, safe, and cost-effective ones. In the present experiment, technetium-99m (99mTc)-labeled PEG-citrate dendrimer-G2 conjugated with glutamine (nanoconjugate) was designed and assessed
Yu-Jen Lu et al.
International journal of molecular sciences, 21(19) (2020-10-01)
In this study, we aimed to develop a multifunctional drug/gene delivery system for the treatment of glioblastoma multiforme by combining the ligand-mediated active targeting and the pH-triggered drug release features of graphene oxide (GO). Toward this end, we load irinotecan

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務